Announcements Trials
Browse Landscape

Status

Completed 38Active not recruiting 12Recruiting 9Terminated 4Withdrawn 3Unknown 3Not yet recruiting 1No longer available 1Enrolling by invitation 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 6Endocrine 2Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Melanoma 2Head and Neck Neoplasms 2Glioblastoma 2Gastrointestinal Neoplasms 2Colorectal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Squamous Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Recurrence 1Osteosarcoma 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasms 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Hepatoblastoma 1Hearing Loss 1Gastrointestinal Stromal Tumors 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Neuroblastoma × Gastrointestinal × Clear all
NCT06872489 2025-07-23

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Second Life Therapeutics

Available
CNSGastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neuroblastoma, Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡